Targeting Intracellular Pathways in Atopic Dermatitis with Small Molecule Therapeutics.

Curr Issues Mol Biol · 2025 · PMC12384770 · PMID 40864813

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The primary endpoint of EASI-75 score reduction did not reach statistical significance, but some efficacy was observed for etrasimod 2 mg on other clinical measures.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.